Brief: China Regenerative Medicine International Announces Lapse Of Cooperation Agreement
17/12/2019 11:23
Dec 17 (Reuters) - China Regenerative Medicine International
Ltd 8158.HK :
* CO-OPERATION AGREEMENT BETWEEN UNIT AND MISKAWAAN BIOTECH
LIMITED HAD LAPSED AND WILL NOT BE PROCEEDED
Source text for Eikon: urn:newsml:reuters.com:*:nHKS8sDdJq
Further company coverage: 8158.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Regenerative Medicine International
See all newsBrief: China Regenerative Medicine International Expects FY Profit To Increase At Least 28%
Brief: China Regenerative Medicine International Says Yan Shibin Will Be Appointed As CFO
Brief: China Regenerative Medicine International Posts H1 Revenue Of HKD59.78 Mln
Brief: China Regenerative Medicine International Posts FY Loss Attributable HK$107.7 Mln
Brief: China Regenerative Medicine International Says Subscription Of Increased Registered Capital